68 related articles for article (PubMed ID: 17651041)
1. Single-cell dosimetry for radioimmunotherapy of B-cell lymphoma patients with special reference to leukemic spread.
Hindorf C; Emfietzoglou D; Lindén O; Bousis C; Fotopoulos A; Kostarelos K; Flux GD
Cancer Biother Radiopharm; 2007 Jun; 22(3):357-66. PubMed ID: 17651041
[TBL] [Abstract][Full Text] [Related]
2. Internal microdosimetry for single cells in radioimmunotherapy of B-cell lymphoma.
Hindorf C; Emfietzoglou D; Lindén O; Kostarelos K; Strand SE
Cancer Biother Radiopharm; 2005 Apr; 20(2):224-30. PubMed ID: 15869460
[TBL] [Abstract][Full Text] [Related]
3. Monte Carlo single-cell dosimetry of I-131, I-125 and I-123 for targeted radioimmunotherapy of B-cell lymphoma.
Bousis C; Emfietzoglou D; Nikjoo H
Int J Radiat Biol; 2012 Dec; 88(12):908-15. PubMed ID: 22348681
[TBL] [Abstract][Full Text] [Related]
4. Monte Carlo single-cell dosimetry of Auger-electron emitting radionuclides.
Bousis C; Emfietzoglou D; Hadjidoukas P; Nikjoo H
Phys Med Biol; 2010 May; 55(9):2555-72. PubMed ID: 20393237
[TBL] [Abstract][Full Text] [Related]
5. Monte Carlo dosimetry of a realistic multicellular model of follicular lymphoma in a context of radioimmunotherapy.
Bordes J; Incerti S; Mora-Ramirez E; Tranel J; Rossi C; Bezombes C; Bordenave J; Bardiès M; Brown R; Bordage MC
Med Phys; 2020 Oct; 47(10):5222-5234. PubMed ID: 32623743
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of methods for red marrow dosimetry based on patients undergoing radioimmunotherapy.
Hindorf C; Lindén O; Tennvall J; Wingårdh K; Strand SE
Acta Oncol; 2005; 44(6):579-88. PubMed ID: 16165917
[TBL] [Abstract][Full Text] [Related]
7. Change in tumor-absorbed dose due to decrease in mass during fractionated radioimmunotherapy in lymphoma patients.
Hindorf C; Lindén O; Stenberg L; Tennvall J; Strand SE
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):4003S-6S. PubMed ID: 14506200
[TBL] [Abstract][Full Text] [Related]
8. Three methods assessing red marrow dosimetry in lymphoma patients treated with radioimmunotherapy.
Ferrer L; Kraeber-Bodéré F; Bodet-Milin C; Rousseau C; Le Gouill S; Wegener WA; Goldenberg DM; Bardiès M
Cancer; 2010 Feb; 116(4 Suppl):1093-100. PubMed ID: 20127958
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35.
Elgqvist J; Andersson H; Bäck T; Hultborn R; Jensen H; Karlsson B; Lindegren S; Palm S; Warnhammar E; Jacobsson L
J Nucl Med; 2005 Nov; 46(11):1907-15. PubMed ID: 16269606
[TBL] [Abstract][Full Text] [Related]
10. In vitro cytotoxicity of low-dose-rate radioimmunotherapy by the alpha-emitting radioimmunoconjugate Thorium-227-DOTA-rituximab.
Dahle J; Krogh C; Melhus KB; Borrebaek J; Larsen RH; Kvinnsland Y
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):886-95. PubMed ID: 19679402
[TBL] [Abstract][Full Text] [Related]
11. A comparison of 4 radionuclides conjugated to antibodies for single-cell kill.
Michel RB; Brechbiel MW; Mattes MJ
J Nucl Med; 2003 Apr; 44(4):632-40. PubMed ID: 12679410
[TBL] [Abstract][Full Text] [Related]
12. Dose to tissue medium or water cavities as surrogate for the dose to cell nuclei at brachytherapy photon energies.
Enger SA; Ahnesjö A; Verhaegen F; Beaulieu L
Phys Med Biol; 2012 Jul; 57(14):4489-500. PubMed ID: 22722477
[TBL] [Abstract][Full Text] [Related]
13. 3D calculation of absorbed dose for 131I-targeted radiotherapy: a Monte Carlo study.
Saeedzadeh E; Sarkar S; Abbaspour Tehrani-Fard A; Ay MR; Khosravi HR; Loudos G
Radiat Prot Dosimetry; 2012 Jul; 150(3):298-305. PubMed ID: 22069233
[TBL] [Abstract][Full Text] [Related]
14. Photon contribution to tumor dose from considerations of 131I radiolabeled antibody uptake in liver, spleen, and whole body.
Johnson TK; Colby SB
Med Phys; 1993; 20(6):1667-74. PubMed ID: 8309439
[TBL] [Abstract][Full Text] [Related]
15. Cellular kinetics, dosimetry, and radiobiology of alpha-particle radioimmunotherapy: induction of apoptosis.
Macklis RM; Lin JY; Beresford B; Atcher RW; Hines JJ; Humm JL
Radiat Res; 1992 May; 130(2):220-6. PubMed ID: 1574578
[TBL] [Abstract][Full Text] [Related]
16. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
[TBL] [Abstract][Full Text] [Related]
17. 131I-Lym-1 in mice implanted with human Burkitt's lymphoma (Raji) tumors: loss of tumor specificity due to radiolysis.
DeNardo GL; DeNardo SJ; Wessels BW; Kukis DL; Miyao N; Yuan A
Cancer Biother Radiopharm; 2000 Dec; 15(6):547-60. PubMed ID: 11190487
[TBL] [Abstract][Full Text] [Related]
18. A model of cellular dosimetry for macroscopic tumors in radiopharmaceutical therapy.
Hobbs RF; Baechler S; Fu DX; Esaias C; Pomper MG; Ambinder RF; Sgouros G
Med Phys; 2011 Jun; 38(6):2892-903. PubMed ID: 21815364
[TBL] [Abstract][Full Text] [Related]
19. Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice.
Riccobene TA; Miceli RC; Lincoln C; Knight Y; Meadows J; Stabin MG; Sung C
J Nucl Med; 2003 Mar; 44(3):422-33. PubMed ID: 12621010
[TBL] [Abstract][Full Text] [Related]
20. Therapy of small subcutaneous B-lymphoma xenografts with antibodies conjugated to radionuclides emitting low-energy electrons.
Michel RB; Rosario AV; Andrews PM; Goldenberg DM; Mattes MJ
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):777-86. PubMed ID: 15701868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
